Description
PARKINSON’S DISEASE – D. Berg, R. Krger, O. Rie, and P. Riederer.- DIAGNOSIS AND NEUROPROTECTION IN PARKINSON’S DISEASE – T. Mller.- UPDATE ON PARKINSON’S DISEASE GENETICS – R. Krger, D. Berg, O. Rie, and P. Riederer.- LRRK2-ASSOCIATED PARKINSONISM – M. Toft, M. J. Farrer, J. O. Aasly, D. W. Dickson, and Z. K. Wszolek.- GENE AND PROTEIN EXPRESSION PROFILING IN PARKINSON’S DISEASE: QUEST FOR NEUROPROTECTIVE DRUGS – O. Weinreb, T. Amit, E. Grnblatt, P. Riederer, M. Youdim, and S. Mandel.- NEUROPROTECTIVE MECHANISMS: OXIDATIVE STRESS AS A TARGET FOR NEUROPROTECTIVE THERAPIES IN ALZHEIMER’S AND PARKINSON’S DISEASE – A. Huber, A. Brkle, and G. Mnch.- DRUG TREATMENT OF MOTOR SYMPTOMS IN PARKINSON’S DISEASE – T. Mller.- PROGRESSIVE SUPRANUCLEAR PALSY AND CORTICOBASAL DEGENERATION – F. Geser, S. W. Scholz, and G. K. Wenning.- CENTRAL TREMORS – T. Glckler and H. Reichmann.- MOLECULAR MECHANISMS OF METHAMPHETAMINE-INDUCED NEUROTOXICITY: INSIGHTS OBTAINED THROUGH cDNA ARRAY ANALYSES – S. Jayanthi, M. T. McCoy, and J. L. Cadet.- HUNTINGTON’S DISEASE: UNRAVELING THE PATHOPHYSIOLOGICAL CASCADE BEHIND A SINGULAR GENE DEFECT – C. M. Kosinski, B. Landwehrmeyer, and A. Ludolph.- DEMENTIA: THE SIGNIFICANCE OF CEREBRAL METABOLIC DISTURBANCES IN ALZHEIMER’S DISEASE. RELATION TO PARKINSON’S DISEASE – S. Hoyer and L. Frlich.- PROTEOMICS ANALYSIS IN ALZHEIMER’S DISEASE: NEW INSIGHTS INTO MECHANISMS OF NEURODEGERATION – D. A. Butterfield and R. Sultana.- VASCULAR DEMENTIA – A. Cagnin and L. Battistin.- LEWY BODY DISORDERS – K. A. Jellinger.- GENE HUNTING BY SUBSTRACTIVE HYBRIDIZATION IN DOWN SYNDROME CORRELATION WITH PROTEOMICS ANALYSIS – O. Golubnitschaja and M. Fountoulakis.- HIV DEMENTIA: A NEURODEGENERATIVE DISORDER WITH VIRAL ETIOLOGY – E. Koutsilieri, G. Arendt, E. Neuen-Jacob, C. Scheller, E. Grnblatt, and P. Riederer.- MULTIPLE SCLEROSIS AND AUTOIMMUNE ENCEPHALOMYELITIS – H. Lassmann.- NEUROPATHIC PAIN – C. Briani, L. Padua, C. Pazaglia, and L. Battistin. PARKINSON’S DISEASE – D. Berg, R. Krger, O. Rie, and P. Riederer.- DIAGNOSIS AND NEUROPROTECTION IN PARKINSON’S DISEASE – T. Mller.- UPDATE ON PARKINSON’S DISEASE GENETICS – R. Krger, D. Berg, O. Rie, and P. Riederer.- LRRK2-ASSOCIATED PARKINSONISM – M. Toft, M. J. Farrer, J. O. Aasly, D. W. Dickson, and Z. K. Wszolek.- GENE AND PROTEIN EXPRESSION PROFILING IN PARKINSON’S DISEASE: QUEST FOR NEUROPROTECTIVE DRUGS – O. Weinreb, T. Amit, E. Grnblatt, P. Riederer, M. Youdim, and S. Mandel.- NEUROPROTECTIVE MECHANISMS: OXIDATIVE STRESS AS A TARGET FOR NEUROPROTECTIVE THERAPIES IN ALZHEIMER’S AND PARKINSON’S DISEASE – A. Huber, A. Brkle, and G. Mnch.- DRUG TREATMENT OF MOTOR SYMPTOMS IN PARKINSON’S DISEASE – T. Mller.- PROGRESSIVE SUPRANUCLEAR PALSY AND CORTICOBASAL DEGENERATION – F. Geser, S. W. Scholz, and G. K. Wenning.- CENTRAL TREMORS – T. Glckler and H. Reichmann.- MOLECULAR MECHANISMS OF METHAMPHETAMINE-INDUCED NEUROTOXICITY: INSIGHTS OBTAINED THROUGH cDNA ARRAY ANALYSES – S. Jayanthi, M. T. McCoy, and J. L. Cadet.- HUNTINGTON’S DISEASE: UNRAVELING THE PATHOPHYSIOLOGICAL CASCADE BEHIND A SINGULAR GENE DEFECT – C. M. Kosinski, B. Landwehrmeyer, and A. Ludolph.- DEMENTIA: THE SIGNIFICANCE OF CEREBRAL METABOLIC DISTURBANCES IN ALZHEIMER’S DISEASE. RELATION TO PARKINSON’S DISEASE – S. Hoyer and L. Frlich.- PROTEOMICS ANALYSIS IN ALZHEIMER’S DISEASE: NEW INSIGHTS INTO MECHANISMS OF NEURODEGERATION – D. A. Butterfield and R. Sultana.- VASCULAR DEMENTIA – A. Cagnin and L. Battistin.- LEWY BODY DISORDERS – K. A. Jellinger.- GENE HUNTING BY SUBSTRACTIVE HYBRIDIZATION IN DOWN SYNDROME CORRELATION WITH PROTEOMICS ANALYSIS – O. Golubnitschaja and M. Fountoulakis.- HIV DEMENTIA: A NEURODEGENERATIVE DISORDER WITH VIRAL ETIOLOGY – E. Koutsilieri, G. Arendt, E. Neuen-Jacob, C. Scheller, E. Grnblatt, and P. Riederer.- MULTIPLE SCLEROSIS AND AUTOIMMUNE ENCEPHALOMYELITIS – H. Lassmann.- NEUROPATHIC PAIN – C. Briani, L. Padua, C. Pazaglia, and L. Battistin.
